Top-News
Biotechnologie USA

Fate Therapeutics Inc Aktie

Aktie
WKN:  A1W50M ISIN:  US31189P1021 US-Symbol:  FATE
1,33 $
+0,105 $
+8,57%
1,1766 € 20:39:17 Uhr
Depot/Watchlist
Aktienanzahl *
113,89 Mio.
Marktkapitalisierung *
130,18 Mio. €
Streubesitz
7,98%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.03.2025

Fate Therapeutics Inc News

18.01.25 - Börse-Global
Fate Therapeutics Aktie: Aktuelle Einschätzungen und Voraussagen
Die Fate Therapeutics Aktie verzeichnete am 18. Januar einen moderaten Anstieg von 1,60 Prozent auf 1,27 USD, was einer positiven Veränderung von 0,02 USD gegenüber dem ...
22.12.24 - Börse-Global
Fate Therapeutics Aktie: Unterschätzte Risiken
Die Fate Therapeutics Aktie zeigt sich zum Jahresende in einer herausfordernden Position. Der Biotechnologie-​Konzern, der sich auf die Entwicklung programmierter zellulärer ...
15.12.24 - Börse-Global
Fate Therapeutics Aktie: Vorzeichen deuten auf Schwierigkeiten hin
Die Fate Therapeutics Aktie verzeichnet aktuell eine herausfordernde Phase an den Börsen. Der Biotechnologie-​Konzern aus San Diego notiert mit einem Kurs von 1,76 EUR ...
13.06.24 - PR Newswire
FATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the Firm
FATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the ...
22.03.23 - PR Newswire
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ ...
21.03.23 - PR Newswire
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders PR Newswire
20.03.23 - PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023 PR Newswire
18.03.23 - PR Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATE
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important March 22 Deadline in ...
17.03.23 - PR Newswire
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire
15.03.23 - PR Newswire
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ ...
14.03.23 - PR Newswire
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders PR Newswire
13.03.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ...
13.03.23 - PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023 PR Newswire
11.03.23 - PR Newswire
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATE
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important March 22 Deadline in Securities ...
10.03.23 - PR Newswire
FATE SHAREHOLDER ALERT: Jakubowitz Law Reminds Fate Shareholders of a Lead Plaintiff Deadline of March 22, 2023
FATE SHAREHOLDER ALERT: Jakubowitz Law Reminds Fate Shareholders of a Lead Plaintiff Deadline of March 22, 2023 PR Newswire
09.03.23 - PR Newswire
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire
07.03.23 - PR Newswire
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders PR Newswire
06.03.23 - PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023 PR Newswire
04.03.23 - PR Newswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE ...
02.03.23 - PR Newswire
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
30.04.25 +22,47%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »